IP Library Granted Patent US 7,888,108
Granted Patent B2
US 7,888,108 · App. 11/811,501 · Granted Feb 15, 2011

Device and method for multiple analyte detection

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,888,108
App. No.
11/811,501
Granted
Feb 15, 2011
Kind
B2
Abstract

The invention is directed to a method and device for simultaneously testing a sample for the presence, presence, and/or amounts of one or more of a plurality of selected analytes. The invention includes, in one aspect, device for detecting or quantitating a plurality of different analytes in a liquid sample. Each chamber may include analyte-specific reagent effective to react with a selected analyte that may be present in the sample, and detection means for detecting the signal. Also disclosed are methods utilizing the device.

Claims (18)

1. A method of detecting or quantitating a target nucleic acid sequence in a liquid sample, comprising:

pre-loading a first unlabeled oligonucleotide into a chamber;

pre-loading a second unlabeled oligonucleotide into the chamber;

introducing a liquid sample comprising a target nucleic acid sequence into the chamber, after the pre-loading of the first unlabeled oligonucleotide and of the second unlabeled oligonucleotide;

mixing the liquid sample with the first unlabeled oligonucleotide and the second unlabeled oligonucleotide, in the chamber, such that the first unlabeled oligonucleotide and the second unlabeled oligonucleotide are not immobilized in the chamber;

reacting the target nucleic acid sequence with both the first unlabeled oligonucleotide and the second unlabeled oligonucleotide in the chamber, to form a reaction product in the chamber;

reacting the reaction product, in the chamber, with a non-immobilized optically detectable detection reagent that is specific for the target nucleic acid sequence, wherein the non-immobilized optically detectable detection reagent is pre-loaded into the chamber before the introducing of the sample; and

detecting the non-immobilized optically detectable detection reagent to detect or quantitate the target nucleic acid sequence.

2. The method of claim 1 , wherein reacting the target nucleic acid sequence with both the first unlabeled oligonucleotide and the second unlabeled oligonucleotide in the chamber, to form a reaction product in the chamber, comprises at least one of a polymerase chain reaction, a ligase chain reaction, an oligonucleotide ligation assay, and a hybridization assay.

3. The method of claim 1 , wherein the first unlabeled oligonucleotide and the second unlabeled oligonucleotide comprise a primer pair suitable for amplifying the target nucleic acid sequence.

4. The method of claim 1 , wherein at least one of the first unlabeled oligonucleotide and the second unlabeled oligonucleotide comprises a sequence that is complementary to at least a portion of the target nucleic acid sequence.

5. The method of claim 1 , wherein the reaction product is detected through an optically transparent window in the chamber.

6. The method of claim 1 , wherein the target nucleic acid sequence is introduced into the chamber by vacuum action.

7. The method of claim 1 , wherein at least one of the pre-loaded first unlabelled oligonucleotide and the pre-loaded second unlabelled oligonucleotide are dried in the chamber prior to the mixing.

8. The method of claim 1 , wherein the optically detectable detection reagent comprises a fluorescent dye.

9. The method of claim 1 , wherein the optically detectable detection reagent comprises a fluorescer dye and a quencher dye.

10. The method of claim 1 , wherein at least one of the first unlabeled oligonucleotide and the second unlabeled oligonucleotide comprises a polynucleotide analog.

11. The method of claim 1 , wherein the first unlabeled oligonucleotide and the second unlabeled oligonucleotide bind to adjacent, contiguous regions of the target nucleic acid sequence.

Assignments (3)
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 030182/0677 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023985/0801 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: APPLIED BIOSYSTEMS, LLC
To: BANK OF AMERICA, N.A, AS COLLATERAL AGENT
Reel/Frame 021976/0001 →